MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL)

CUSIP: 558868105

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / Common Stock
Shares outstanding
22,766,960
Total 13F shares
5,126,558
Share change
+2,451,017
Total reported value
$470,559,417
Price per share
$91.79
Number of holders
88
Value change
+$234,134,618
Number of buys
70
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 558868105?
CUSIP 558868105 identifies MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
2.4%
553,570
$24,900,000 30 Sep 2017
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
2.2%
500,000
$22,490,000 30 Sep 2017
13F
Rock Springs Capital Management LP
13F
Company
1.2%
275,000
$12,370,000 30 Sep 2017
13F
ARMISTICE CAPITAL, LLC
13F
Company
0.93%
212,000
$9,536,000 30 Sep 2017
13F
BlackRock Finance, Inc.
13F
Company
0.81%
183,778
$8,266,000 30 Sep 2017
13F
VANGUARD GROUP INC
13F
Company
0.63%
143,443
$6,452,000 30 Sep 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.56%
127,287
$5,725,000 30 Sep 2017
13F
Foresite Capital Management III, LLC
13F
Company
0.44%
100,000
$4,498,000 30 Sep 2017
13F
ASCEND CAPITAL, LLC
13F
Company
0.32%
73,515
$3,307,000 30 Sep 2017
13F
BAKER BROS. ADVISORS LP
13F
Company
0.25%
57,762
$2,598,000 30 Sep 2017
13F
NORTHERN TRUST CORP
13F
Company
0.23%
52,796
$2,374,000 30 Sep 2017
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.22%
50,556
$2,274,000 30 Sep 2017
13F
STATE STREET CORP
13F
Company
0.2%
44,820
$2,012,000 30 Sep 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.19%
42,362
$1,905,000 30 Sep 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.16%
35,980
$1,618,000 30 Sep 2017
13F
VHCP Management II, LLC
13F
Company
0.13%
30,000
$1,349,000 30 Sep 2017
13F
NEXTHERA CAPITAL LP
13F
Company
0.13%
28,536
$1,284,000 30 Sep 2017
13F
Sio Capital Management, LLC
13F
Company
0.12%
26,958
$1,213,000 30 Sep 2017
13F
SHIKIAR ASSET MANAGEMENT INC
13F
Company
0.1%
23,141
$1,041,000 30 Sep 2017
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.06%
13,800
$621,000 30 Sep 2017
13F
Bank of New York Mellon Corp
13F
Company
0.06%
12,942
$582,000 30 Sep 2017
13F
ROYAL BANK OF CANADA
13F
Company
0.04%
9,553
$430,000 30 Sep 2017
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.04%
8,304
$374,000 30 Sep 2017
13F
Cambridge Investment Research Advisors, Inc.
13F
Company
0.03%
7,857
$353,000 30 Sep 2017
13F
JPMORGAN CHASE & CO
13F
Company
0.03%
7,027
$325,000 30 Sep 2017
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.03%
6,700
$301,000 30 Sep 2017
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.03%
6,600
$297,000 30 Sep 2017
13F
Virtu Financial LLC
13F
Company
0.03%
6,241
$281,000 30 Sep 2017
13F
MORGAN STANLEY
13F
Company
0.02%
5,646
$255,000 30 Sep 2017
13F
ELLINGTON MANAGEMENT GROUP LLC
13F
Company
0.02%
5,500
$247,000 30 Sep 2017
13F
TEACHERS ADVISORS, LLC
13F
Company
0.02%
4,871
$219,000 30 Sep 2017
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.01%
2,710
$122,000 30 Sep 2017
13F
SG Americas Securities, LLC
13F
Company
0.01%
2,232
$100,000 30 Sep 2017
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.01%
2,154
$96,000 30 Sep 2017
13F
Nationwide Fund Advisors
13F
Company
0.01%
2,065
$93,000 30 Sep 2017
13F
FNY Partners Fund LP
13F
Company
0.01%
1,500
$67,000 30 Sep 2017
13F
STRS OHIO
13F
Company
0.01%
1,200
$53,000 30 Sep 2017
13F
UBS Group AG
13F
Company
0%
1,031
$46,000 30 Sep 2017
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
950
$42,000 30 Sep 2017
13F
Legal & General Group Plc
13F
Company
0%
773
$35,000 30 Sep 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
418
$19,000 30 Sep 2017
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
395
$17,767 30 Sep 2017
13F
Evercore Wealth Management, LLC
13F
Company
0%
354
$16,000 30 Sep 2017
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
225
$10,000 30 Sep 2017
13F
Steward Partners Investment Advisory, LLC
13F
Company
0%
171
$7,000 30 Sep 2017
13F
FEDERATED HERMES, INC.
13F
Company
0%
163
$7,000 30 Sep 2017
13F
Ameritas Investment Partners, Inc.
13F
Company
0%
355
$6,000 30 Sep 2017
13F
BARCLAYS PLC
13F
Company
0%
95
$4,000 30 Sep 2017
13F
LADENBURG THALMANN FINANCIAL SERVICES INC.
13F
Company
0%
42
$2,000 30 Sep 2017
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0%
31
$1,394 30 Sep 2017
13F

Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q4 2017

As of 31 Dec 2017, MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) was held by 88 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,126,558 shares. The largest 10 holders included FMR LLC, BAKER BROS. ADVISORS LP, ADAGE CAPITAL PARTNERS GP, L.L.C., CITADEL ADVISORS LLC, Rock Springs Capital Management LP, Vanguard Group Inc, BlackRock Inc., VICTORY CAPITAL MANAGEMENT INC, JENNISON ASSOCIATES LLC, and PERCEPTIVE ADVISORS LLC. This page lists 88 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2017 vs Q3 2017 Across Filers

Q3 2017 holders
50
Q4 2017 holders
88
Holder diff
38
Investor Q3 2017 Shares Q4 2017 Shares Share Diff Share Chg % Q3 2017 Value $ Q4 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.